Strata Skin Sciences Total Current Liabilities 2010-2025 | SSKN
Strata Skin Sciences Annual Total Current Liabilities (Millions of US $) |
|
---|---|
2024 | $15 |
2023 | $12 |
2022 | $13 |
2021 | $13 |
2020 | $19 |
2019 | $17 |
2018 | $9 |
2017 | $10 |
2016 | $6 |
2015 | $7 |
2014 | $2 |
2013 | $6 |
2012 | $3 |
2011 | $1 |
2010 | $2 |
2009 | $2 |
Strata Skin Sciences Quarterly Total Current Liabilities (Millions of US $) |
|
---|---|
2025-03-31 | $15 |
2024-12-31 | $15 |
2024-09-30 | $14 |
2024-06-30 | $12 |
2024-03-31 | $13 |
2023-12-31 | $12 |
2023-09-30 | $12 |
2023-06-30 | $14 |
2023-03-31 | $13 |
2022-12-31 | $13 |
2022-09-30 | $14 |
2022-06-30 | $14 |
2022-03-31 | $14 |
2021-12-31 | $13 |
2021-09-30 | $12 |
2021-06-30 | $18 |
2021-03-31 | $20 |
2020-12-31 | $19 |
2020-09-30 | $19 |
2020-06-30 | $17 |
2020-03-31 | $17 |
2019-12-31 | $17 |
2019-09-30 | $12 |
2019-06-30 | $11 |
2019-03-31 | $10 |
2018-12-31 | $9 |
2018-09-30 | $5 |
2018-06-30 | $4 |
2018-03-31 | $9 |
2017-12-31 | $10 |
2017-09-30 | $6 |
2017-06-30 | $8 |
2017-03-31 | $8 |
2016-12-31 | $6 |
2016-09-30 | $5 |
2016-06-30 | $4 |
2016-03-31 | $6 |
2015-12-31 | $7 |
2015-09-30 | $15 |
2015-06-30 | $17 |
2015-03-31 | $4 |
2014-12-31 | $2 |
2014-09-30 | $4 |
2014-06-30 | $5 |
2014-03-31 | $11 |
2013-12-31 | $6 |
2013-09-30 | $3 |
2013-06-30 | $4 |
2013-03-31 | $2 |
2012-12-31 | $3 |
2012-09-30 | $2 |
2012-06-30 | $2 |
2012-03-31 | $2 |
2011-12-31 | $1 |
2011-09-30 | $1 |
2011-06-30 | $1 |
2011-03-31 | $2 |
2010-12-31 | $2 |
2010-09-30 | $2 |
2010-06-30 | $2 |
2010-03-31 | $2 |
2009-12-31 | $2 |
2009-09-30 | $2 |
2009-06-30 | $1 |
2009-03-31 | $1 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.010B | $0.034B |
Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $45.332B | 57.93 |
Hims & Hers Health (HIMS) | United States | $12.707B | 132.02 |
Tempus AI (TEM) | United States | $10.988B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.490B | 0.00 |
Inspire Medical Systems (INSP) | United States | $3.944B | 61.63 |
Hinge Health (HNGE) | United States | $3.156B | 0.00 |
Privia Health (PRVA) | United States | $2.783B | 190.25 |
Enovis (ENOV) | United States | $1.694B | 9.44 |
Clover Health Investments (CLOV) | United States | $1.613B | 0.00 |
Schrodinger (SDGR) | United States | $1.592B | 0.00 |
Phreesia (PHR) | United States | $1.482B | 0.00 |
Omnicell (OMCL) | United States | $1.415B | 24.96 |
Azenta (AZTA) | United States | $1.219B | 56.66 |
10x Genomics (TXG) | United States | $1.164B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.629B | 0.00 |
Claritev (CTEV) | United States | $0.629B | 0.00 |
Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
Talkspace (TALK) | United States | $0.561B | 167.50 |
Veradigm (MDRX) | United States | $0.466B | 0.00 |
Standard BioTools (LAB) | United States | $0.399B | 0.00 |
TruBridge (TBRG) | United States | $0.357B | 791.67 |
Outset Medical (OM) | United States | $0.316B | 0.00 |
Health Catalyst (HCAT) | United States | $0.264B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.260B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.194B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.136B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
Pulmonx (LUNG) | United States | $0.126B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
American Well (AMWL) | United States | $0.103B | 0.00 |
CareCloud (CCLD) | United States | $0.085B | 3.26 |
111 (YI) | China | $0.070B | 0.00 |
HeartBeam (BEAT) | United States | $0.061B | 0.00 |
P3 Health Partners (PIII) | United States | $0.051B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.034B | 0.00 |
Zhongchao (ZCMD) | China | $0.030B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
Precipio (PRPO) | United States | $0.016B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
Movano (MOVE) | United States | $0.004B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |